Drug
Etoricoxib
Etoricoxib: highest development phase Phase 3, developed by Merck. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Merck
Trials
| Drug | Phase | Indication |
|---|---|---|
| Etoricoxib 60 mg NCT00876317 | Phase 3 | Soft Tissue Injuries of the Shoulder |
Latest
No recent events.
Follow Etoricoxib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.